Literature DB >> 8057454

Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1.

S Michelson1, J Alcami, S J Kim, D Danielpour, F Bachelerie, L Picard, C Bessia, C Paya, J L Virelizier.   

Abstract

Human cytomegalovirus (CMV) infection can elicit a transitory, but profound, immunodepression in immunocompetent individuals. Cytopathogenic destruction of CMV-infected leukocytes alone does not seem sufficient to explain this phenomenon, which suggests that immune system mediators (cytokines) may play a role in amplifying local modifications wrought by CMV infection. We reported previously that transforming growth factor beta 1 (TGF-beta 1) stimulates CMV replication (J. Alcami, C. V. Paya, J. L. Virelizier, and S. Michelson, J. Gen. Virol. 74:269-274, 1993). Since TGF-beta 1 can have profound negative effects on cell growth and immune responses, we investigated the induction of TGF-beta 1 following CMV infection of permissive fibroblasts. TGF-beta 1 promoter was activated by immediate-early (IE) proteins in the absence of infection and transactivated at 5 and 9 h after infection. TGF-beta 1 mRNA increased during the early phase of infection, suggesting that this phenomenon is due to enhanced transcription of the TGF-beta 1 gene. A comparative study of the influence of CMV infection and IE protein expression on TGF-beta 1 promoter function in permissive cells pointed to a possible cooperative role between IE proteins and protein(s) expressed during the early phase of viral infection. Induction of TGF-beta 1 by CMV infection could modify infected cells individually, surrounding tissues, and systemic immune reactions to the advantage of virus replication by both upregulating CMV replication and downregulating host immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057454      PMCID: PMC236976     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene.

Authors:  S J Kim; A Glick; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor.

Authors:  E N Benveniste; J E Merrill; S E Kaufman; D W Golde; J C Gasson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  The TGF-beta family of growth and differentiation factors.

Authors:  J Massagué
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

4.  Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; V Iacoviello; M S Hirsch
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

6.  Interferon induction in human leukocytes after in vitro exposure to cytomegalovirus or Epstein-Barr virus.

Authors:  L Einhorn; S Einhorn; B Wahren
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

7.  Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells.

Authors:  J C Jennings; S Mohan; T A Linkhart; R Widstrom; D J Baylink
Journal:  J Cell Physiol       Date:  1988-10       Impact factor: 6.384

8.  Similarity between the vaccinia virus 19K early protein and epidermal growth factor.

Authors:  A H Reisner
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus.

Authors:  M C Pizzorno; P O'Hare; L Sha; R L LaFemina; G S Hayward
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

Review 10.  Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors:  M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  50 in total

1.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

2.  Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.

Authors:  E Drouet; C Chapuis-Cellier; S Bosshard; C Verniol; A Niveleau; J L Touraine; J L Garnier
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  TAF-like functions of human cytomegalovirus immediate-early proteins.

Authors:  D M Lukac; N Y Harel; N Tanese; J C Alwine
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.

Authors:  Kristine Dziurzynski; Jun Wei; Wei Qiao; Mustafa Aziz Hatiboglu; Ling-Yuan Kong; Adam Wu; Yongtao Wang; Daniel Cahill; Nicholas Levine; Sujit Prabhu; Ganesh Rao; Raymond Sawaya; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2011-04-13       Impact factor: 12.531

5.  Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus.

Authors:  Claire Gealy; Marian Denson; Christine Humphreys; Brian McSharry; Gavin Wilkinson; Richard Caswell
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse.

Authors:  S Charan; K Palmer; P Chester; A R Mire-Sluis; A Meager; N Edington
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma.

Authors:  H P Steffens; J Podlech; S Kurz; P Angele; D Dreis; M J Reddehase
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

Authors:  Takako Tabata; Hisaaki Kawakatsu; Ekaterina Maidji; Takao Sakai; Keiko Sakai; June Fang-Hoover; Motohiko Aiba; Dean Sheppard; Lenore Pereira
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

10.  Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter.

Authors:  Jing Qing; Cheng Liu; Lisa Choy; Rui-Yun Wu; Joseph S Pagano; Rik Derynck
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.